This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

The Deal: Suntory to Pay $2.1B for GSK Drinks Brands

Stocks in this article: GSK

By Laura Board In London

LONDON ( The Deal) -- GlaxoSmithKline on Monday, Sept. 9, confirmed a deal to sell its Lucozade and Ribena drinks brands to Japan's Suntory Beverage & Food Ltd. for 1.35 billion pounds ($2.1 billion).

The price, the outcome of a preemptive bid which stalled a full-blown auction, is above most expectations. GlaxoSmithKline, which is shedding the popular British drinks to focus on bona-fide consumer healthcare products with greater traction in emerging markets, said it will receive net proceeds of 1.3 billion pounds and will use these to cut debt and for general corporate purposes.

"Lucozade and Ribena are iconic brands that have made a huge contribution to GSK over the years, but now is the right time to sell them as we increase the focus of our Consumer Healthcare business and execute the delivery of our late stage pipeline of pharmaceuticals and vaccines," said GlaxoSmithKline Chief Strategy Officer David Redfern in a statement.

For Suntory Beverage, the acquisition marks a major push into Britain and its first large deal since it raised 388 billion yen ($3.9 billion) in an initial public offering in late June, with proceeds earmarked for a planned 500 billion yen acquisition drive as it seeks to double sales to 2 trillion yen by 2020 through overseas expansion.

Suntory Beverage became a significant force in Europe with its acquisition of France's Orangina from Blackstone Group LP and Lion Capital LLP in 2009 for 300 billion yen. (Blackstone and Lion Capital were among the prospective suitors for Ribena and Lucozade before the British company entered late-stage talks with the Japanese bidder). Suntory Beverage is probably best known for its eponymous whiskey, the subject of an ad by Bill Murray's past-his-prime actor Bob Harris in the film "Lost in Translation."

The deal includes a plant in Coleford, near the English-Welsh border. In Nigeria, GlaxoSmithKline will continue to manufacture and distribute the two drinks under license from Suntory Beverage, of Tokyo. Ribena and Lucozade have annual sales of about 500 million pounds, GlaxoSmithKline said Monday.

JPMorgan Chase & Co. and Greenhill & Co. International LLP advised GlaxoSmithKline, which expects the sale to close by year-end.

1 of 2

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,269.43 +200.56 1.18%
S&P 500 1,994.71 +21.97 1.11%
NASDAQ 4,607.2640 +59.43 1.31%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs